Tierarztl Prax Ausg G Grosstiere Nutztiere 2010; 38(S 01): S37-S40
DOI: 10.1055/s-0038-1623025
Ausgewählter Kongressbeitrag
Schattauer GmbH

Aktueller Stand der internistischen Fibrosarkomtherapie bei der Katze

J. Hirschberger
1   Medizinische Kleintierklinik (Leitung: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
06 January 2018 (online)

 

 
  • Literatur

  • 1 Barber LG, Sorenmo KU, Cronin KL. et al. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. J Am Anim Hosp Assoc 2000; 36: 416-421.
  • 2 Buracco P, Martano M, Morello E. et al. Vaccine-associated-like fibrosarcoma at the site of a deep nonabsorbable suture in a cat. Vet J 2002; 163: 105-107.
  • 3 Burton G, Mason KV. Do postvaccinal sarcomas occur in Australian cats?. Aust Vet J 1997; 75: 102-106.
  • 4 Cohen M, Wright JC, Brawner WR. et al. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996–2000). J Am Vet Med Assoc 2001; 219: 1582-1589.
  • 5 Couto CG, Macy DW. Review of treatment options for vaccine-associated feline sarcoma. J Am Vet Med Assoc 1998; 213: 1426-1427.
  • 6 Coyne MJ, Reeves NC, Rosen DK. Estimated prevalence of injection-site sarcomas in cats during 1992. J Am Vet Med Assoc 1997; 210: 249-251.
  • 7 Cronin K, Page RL, Spodnick G. et al. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 1998; 39: 51-56.
  • 8 Daly MK, Saba CF, Crochik SS. et al. Fibrosarcoma adjacent to the site of microchip implantation in a cat. J Feline Med Surg 2008; 10: 202-205.
  • 9 Day MJ, Schoon HA, Magnol JP. et al. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine 2007; 25: 4073-4084.
  • 10 Doddy FD, Glickman LT, Glickman NW. et al. Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol 1996; 114: 165-174.
  • 11 Dubielzig RR, Hawkins KL, Miller PE. Myofibroblastic sarcoma originating at the site of rabies vaccination in a cat. J Vet Diagn Invest 1993; 5: 637-638.
  • 12 Ellis JA, Jackson ML, Bartsch RC. et al. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. J Am Vet Med Assoc 1996; 209: 767-771.
  • 13 Esplin DG, McGill LD, Meininger AC. et al. Postvaccination sarcomas in cats. J Am Vet Med Assoc 1993; 202: 1245-1247.
  • 14 Esplin DG. Fibrosarcoma at the site of a lufenuron injection in a cat. Vet Cancer Soc Newsletter 1999; 23: 8-9.
  • 15 Gagnon A. Drug injection-associated fibrosarcoma in a cat. Feline Pract 2000; 28: 18-21.
  • 16 Gobar GM, Kass PH. World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J Am Vet Med Assoc 2002; 220: 1477-1482.
  • 17 Hampel V, Schwarz B, Kempf C. et al. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega. J Vet Intern Med 2007; 21: 1340-1346.
  • 18 Hendrick MJ, Brooks JJ. Postvaccinal sarcomas in the cat: histology and immunohistochemistry. Vet Pathol 1994; 31: 126-129.
  • 19 Hendrick MJ, Goldschmidt MH. Do injection site reactions induce fibrosarcomas in cats?. J Am Vet Med Assoc 1991; 199: 968.
  • 20 Hendrick MJ, Shofer FS, Goldschmidt MH. et al. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991–1992). J Am Vet Med Assoc 1994; 205: 1425-1429.
  • 21 Hershey AE, Sorenmo KU, Hendrick MJ. et al. Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 2000; 216: 58-61.
  • 22 Hirschberger J, Kessler M. Das feline Fibrosarkom. Tierärztl Prax 2001; 29 (K): 66-71.
  • 23 Hüttinger C, Hirschberger J, Jahnke A. et al. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J Gene Med 2008; 10: 655-667.
  • 24 Jahnke A, Hirschberger J, Fischer C. et al. Intra-tumoral Gene Delivery of feIL-2, feIFN-gamma and feGM-CSF using Magnetofection as a Neoadjuvant Treatment Option for Feline Fibrosarcomas: A Phase-I Study. J Vet Med A Physiol Pathol Clin Med 2007; 54: 599-606.
  • 25 Jourdier TM, Moste C, Bonnet MC. et al. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 2003; 10: 2126-2132.
  • 26 Kamenica K, Brill T, Hirschberger J, Köstlin R, Hermanns W. Vakzineassoziierte feline Fibrosarkome: histopathologische Befunde und Pognose. Tierärztl Prax 2008; 36 (K): 135-141.
  • 27 Kass PH, Barnes Jr. WG, Spangler WL. et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993; 203: 396-405.
  • 28 Kass PH, Spangler WL, Hendrick MJ. et al. Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 2003; 223: 1283-1292.
  • 29 Kidney BA, Ellis JA, Haines DM. et al. Evaluation of formalin-fixed paraffin-embedded tissues obtained from vaccine site-associated sarcomas of cats for DNA of feline immunodeficiency virus. Am J Vet Res 2000; 61: 1037-1041.
  • 30 Kidney BA, Haines DM, Ellis JA. et al. Evaluation of formalin-fixed paraffin-embedded tissues from vaccine site-associated sarcomas of cats for polyomavirus DNA and antigen. Am J Vet Res 2001; 62: 828-832.
  • 31 Kidney BA, Haines DM, Ellis JA. et al. Evaluation of formalin-fixed paraffin-embedded tissues from feline vaccine site-associated sarcomas for feline foamy virus DNA. Am J Vet Res 2002; 63: 60-63.
  • 32 Kidney BA, Haines DM, Ellis JA. et al. Evaluation of formalin-fixed paraffin-embedded tissues from vaccine site-associated sarcomas of cats for papillomavirus DNA and antigen. Am J Vet Res 2001; 62: 833-839.
  • 33 Kobayashi T, Hauck ML, Dodge R. et al. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 2002; 43: 473-479.
  • 34 Lester S, Clemett T, Burt A. Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982–1993). J Am Anim Hosp Assoc 1996; 32: 91-95.
  • 35 Martano M, Morello E, Ughetto M. et al. Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases. Vet J 2005; 170: 84-90.
  • 36 McEntee MC, Page RL. Feline vaccine-associated sarcomas. J Vet Intern Med 2001; 15: 176-182.
  • 37 McEntee MC. The utility of contrast enhanced computed tomography in feline vaccine associated sarcomas: 35 cases. Vet Radiol Ultrasound 2000; 41: 575.
  • 38 Mir LM, Devauchelle P, Quintin-Colonna F. et al. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 1997; 76: 1617-1622.
  • 39 Poirier VJ, Thamm DH, Kurzman ID. et al. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. J Vet Intern Med 2002; 16: 726-731.
  • 40 Quintin-Colonna F, Devauchelle P, Fradelizi D. et al. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2. Gene Ther 1996; 3: 1104-1112.
  • 41 Rassnick KM, Rodriguez CO, Khanna C. et al. Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas. Am J Vet Res 2006; 67: 517-523.
  • 42 Rassnick KM. Feline Vaccine-Associated Sarcomas: The Problem is not over yet. ACVIM Forum. 2006. Louisville, KY: 395-397
  • 43 Sandler I, Teeger M, Best S. Metastatic vaccine associated fibrosarcoma in a 10-year-old cat. Can Vet J 1997; 38: 374.
  • 44 Shaw S, Kent M, Gordon I, Greasby I, Collins C, Hammond G, Skorupski K. Changes in injection site sarcomas in cats from 1990–2006. Proc Vet Cancer Soc, Conference. Fort Lauderdale, Fla: 2007
  • 45 Siddiqui F, Li CY, Larue SM. et al. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Mol Cancer 2007; Ther 6: 380-389.
  • 46 Spugnini EP, Baldi A, Vincenzi B. et al. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 2007; 59: 375-381.
  • 47 Steger-Lieb A, Kostorz A, Hauser B. et al. Einsatz der Strahlentherapie beim vakzineassoziierten Sarkom der Katze, Erfahrungen aus 18 Fällen. Tierärztl Prax 2002; 30 (K): 35-40.
  • 48 Thamm DH. Interactions between radiation therapy and immunotherapy: the best of two worlds?. Veterinary and Comparative Oncology 2006; 4: 189-197.
  • 49 VAFSTF. Vaccine-Associated Feline Sarcoma Task Force guidelines. Diagnosis and treatment of suspected sarcomas. J Am Vet Med Assoc 1999; 214: 1745.